Geranylgeraniol (GGOH) as a Mevalonate Pathway Activator in the Rescue of Bone Cells Treated with Zoledronic Acid: An In Vitro Study
Bisphosphonates (BPs) are the keystone to treat bone disorders. Despite the great benefits of BPs, medication-related osteonecrosis of the jaw (MRONJ) arouse as a potential side effect. Nitrogen-containing BPs (N-BPs) as zoledronate (ZA) act by the inhibition of specific enzymes of the mevalonate pa...
Saved in:
Main Authors: | Riham M. Fliefel, Saleh A. Entekhabi, Michael Ehrenfeld, Sven Otto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/4351327 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization
by: Silvia Codenotti, et al.
Published: (2025-02-01) -
Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
by: Guo-Ping Chen, et al.
Published: (2015-01-01) -
Effects of Zoledronic Acid on Physiologic Bone Remodeling of Condylar Part of TMJ: A Radiologic and Histomorphometric Examination in Rabbits
by: Ufuk Tatli, et al.
Published: (2014-01-01) -
The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
by: I. Putu Eka Widyadharma, et al.
Published: (2024-10-01) -
HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
by: Tri Wahyu Martanto, et al.
Published: (2023-10-01)